Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer
Hagai Ligumsky, Herut Dor, Tal Etan, Inbal Golomb, Alla Nikolaevski‐Berlin, Inbal Greenberg, Tamar Halperin, Yoel Angel, Oryan Henig, Avishay Spitzer, Marina Slobodkin, Ido Wolf
Topics & Concepts
MedicineImmunogenicityVaccinationChristian ministryCancerCoronavirus disease 2019 (COVID-19)MEDLINEInternal medicineImmune systemImmunologyDiseaseLawTheologyPhilosophyPolitical scienceInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesVaccine Coverage and Hesitancy